INTRODUCTION
Coxsackie B viruses are important causes of human disease; the more severe infections involve the central nervous system and the heart (Grist, Bell and Assaad, 1978) . Diagnosis often depends upon detecting specific antibodies because excretion of virus commonly ceases soon after onset of symptoms (Bell and Grist, 1968) . The most reliable serological technique has been the neutralisation test, which detects type-specific antibody responses. However, the neutralisation test is laborious, time consuming and slow and a quicker and simpler technique is needed for diagnostic purposes.
Since its introduction by Engvall and Perlmann (1971) and Van Weemen and Schuurs (1 97 l), the enzyme-linked immunosorbent assay (ELISA) has proved to be a highly sensitive and versatile technique in viral serology, and is capable of detecting type-specific and group-specific antibodies in hyperimmune rabbit sera prepared against various enteroviruses (Herrmann, Hendry and Collins, 1979; Katze and Crowell, 1980a) . We have investigated the specificity of the indirect ELISA technique for detecting Coxsackie-B-virus antibodies in rabbit and human sera, with a view to evaluating its usefulness as a diagnostic test. 
460
GILLIA N HA NNINGTON ET AL.
MATERIALS AND METHODS

Viruses.
Coxsackievirus types B1-B5 were obtained from Dr G. Cambridge, Department of Virology, Hammersmith Hospital, London. Stocks were prepared in continuous African green monkey kidney cells (Vero) and stored at -70°C.
Preparation of purified antigens for the ELISA test. Confluent monolayers of Vero cells in roller bottles were washed three times with phosphate buffered saline (PBS), pH 7.4, reincubated in Eagle's minimal essential medium (MEM) supplemented with glutamine 0.03% for 72 h, and infected with coxsackievirus, c. lo9 plaque-forming units (pfu)/roller bottle (input multiplicity=2 pfu/cell). After adsorption for 1 h at 37"C, the cultures were refed with MEM supplemented with glutamine 0.03% and tryptose-phosphate 1% and incubated at 37°C for 36-60 h, until 3-4+ CPE developed. The supernates were discarded and the infected cells harvested before they had spontaneously detached from the glass by shaking with sterile glass beads. The infected cells were collected into MEM and deposited by centrifugation at 4000 rpm for 1 h. They were resuspended in a small volume of MEM and ruptured by freezing and thawing three times. The cell debris was removed by spinning at 2500 rpm for 30 min and the supernate, containing the virus particles, was stored in small volumes at -70°C until required; the infectivity titres were c. lo7 TCDSO/O.O5 ml. For purification, 2-ml amounts were mixed with 0.2 ml of a 10% solution of sodium lauryl sulphate (Brown et al., 1976) and centrifuged in a preformed linear sucrose giadient (sucrose 15-4574 w/w, in PBS) overlying a cushion of sucrose 60%, for 2 h at 40 000 rpm in the Beckman SW41 rotor. One-ml fractions were harvested, and 90% of the infectivity was recovered within a 1-4 fraction band at the centre of the gradient, well separated from the peak of material dissolved in detergent at the top of the gradient as judged by absorbance measurements at 260 and 280 nm. The purified virus was stored at -70"C, and was subsequently used as antigen for the ELISA test and for the preparation of immune sera in rabbits; infectivity titres ranged from 105'5-107'9 TCDSO/O.OS ml.
Control antigens were prepared in the same way from uninfected Vero cell cultures. Preparation of immune antisera. New Zealand white rabbits, without pre-existing antibodies against Coxsackie B viruses, were given 0.3 ml of purified virus intravenously and a second dose 3 weeks later; they were bled after a further 3 weeks.
Human sera. Serum specimens were available from 50 adults, aged 31-72 years (mean 52 years), who had been examined previously for neutralising antibodies to Coxsackie B virus types 1-5 (Griffiths, Hannington and Booth, 1980) ; they were stored at -20°C. The sera included seven samples without detectable antibody to any of the five viruses, 12 that contained type-specific antibodies reacting with only a single serotype, and 3 1 with neutralising antibodies for two or more serotypes. Paired serum specimens were also available from another four patients; they showed a reproducible four-fold or greater rise in neutralising antibody titre against at least one of the virus serotypes.. Neutralisation technique. Tests were done in Microtitre plates, with Vero cells, as previously described (Griffiths et al., 1980) . ELISA technique. This was performed as described by Booth et al. (1979) , except that viral antigen was fixed to the Microtitre plates by drying at room temperature overnight followed by treatment with formalin 10% for 20 min. The absorbance value (Em) for each serum sample was calculated as the mean of readings of duplicate wells minus the "background" activity in the test; the latter was the mean of the readings from duplicate wells incubated with diluent instead of serum. Serum antibody titration end-points were the lowest dilution of the serum with an E m reading of 0-2; control wells without antigen or with serum specimens without specific antibodies gave readings < 0.2.
Pre-titration of antigens and ELISA conjugates. The conjugates (sheep anti-human IgG and sheep anti-rabbit immunoglobulin, coupled with alkaline phosphatase) and the five purified virus antigens were titrated in parallel in a single chessboard test. Microtitre plates were coated with antigen, in doubling dilutions from 1 in 10 to 1 in 80, and treated with a 1 in 300 dilution of a pool of human sera or rabbit antisera, prepared as described above, containing neutralising antibodies to all five Coxsackie B virus serotypes. Conjugate was then added, in serial two-fold dilutions from 1 in 50 to 1 in 400 in chessboard fashion, and the ELISA test was completed in the usual way. The working dilution for each antigen was taken as the dilution that gave an E4w The neutralisation test showed that the five immune rabbit sera prepared against Coxsackie types B1-5 were type specific (table I). The antibody titres ranged from 64-2048, and there were no cross-reactions with the heterotypic antigens. By ELISA, the homotypic antibody titres were 3-to 35-fold higher than by the neutralisation test, and all five sera showed extensive cross-reactions with heterotypic antigens, although the cross-reacting antibody titres were 2-to %fold lower than the type-specific antibody titres. None of the rabbit pre-immunisation sera had detectable Coxsackie B virus antibodies, either by ELISA or by the neutralisation test. None of the sera reacted significantly with the control antigen, even when tested at a dilution of 1 in 100. 
Tests with human sera
Paired sera from four patients that showed four-fold or greater rises in neutralising antibody levels to one or more of the Coxsackie B virus serotypes were titrated for antibody by ELISA (table 11). All eight sera contained antibodies against all five coxsackieviruses but rising titres were not demonstrated, nor were there significant differences in the antibody levels, in each serum specimen, against the five virus sero types.
Single serum specimens collected from 50 adult patients were examined for coxsackievirus antibodies. By ELISA, all 50 sera had antibodies against all five virus serotypes. However, only 43 had neutralising antibodies against one or more of the viruses; the seven negative sera were also without Coxsackie B6 neutralising antibody. When the neutralising antibody titres of the 50 sera were compared with the ELISA-E~W readings, which are proportional to the ELISA-antibody titres, for each serotype in turn, significant correlations were not demonstrated; r values ranged from 0.20-0.32 (p > 0.1). Similar findings were obtained when the neutralising antibody titres against the five virus serotypes were compared with one another; e.g., comparison of Coxsackie B2 and B5 antibody titres gave r values of 0-17-4-47 (p > 0.1) GILLIAN HANNINGTON ET A L . 1400 (< 8) 1400 (32) (64) 5600 (128) 11200 (16) 8900 ( < 8) 10o00(>1024) 11200 (256) 10000(<8) 4000 (16) 9000 (8) 2200 (32) i 
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( fig. a) . In contrast, the ELISA-E~W readings for the five virus serotypes showed a highly significant correlation; e.g., Coxsackie B2 and B5 antibody titres gave r values of 0-90-0.93 (p=O.OOl) (fig. b) . Em readings were within the range 0-21-1.17 in tests with the viral antigens, and 0.014.16 with the control antigen (mean 0.04, standard deviation 0.03).
The seven sera without neutralising antibodies contained ELISA antibodies against all five Coxsackie B virus serotypes, and the E4w values (0.36-0.57) were within the middle range obtained for the group of 50 sera. 
DISCUSSION
The neutralisation test proved to be, as expected, type-specific in its reactivity but the ELISA test, even with purified virus particles, was essentially group-specific. With the rabbit immune sera, however, there was evidence that ELISA was detecting both group-specific and type-specific antibodies, because the antibody titre against the homologous virus was invariably higher than the titres obtained with the heterologous viruses. This confirms the findings of Herrmann et al. (1979) and Katze and Crowell (1 980a) who demonstrated similar group-and type-specific reactions in indirect-ELISA tests with rabbit antisera and purified Coxsackie B viruses.
Other techniques, such as complement fixation, gel diffusion and indirect immunofluorescence, are also mainly group-reactive in tests for coxsackievirus antibodies (Schmidt, Dennis and Lennette, 1967; Chaudhary and Westwood, 1970) . Group-enteroviral antigens appear to be exposed on naturally occurring incomplete virus particles and on complete virus particles that have been denatured by heating (Schmidt et al., 1963) . Heating results in the loss of the VP4 polypeptide from the virus particle (Breindl, 1971; Maizel, Phillips and Summers, 1967) or in gross conformational re-arrangement of the proteins of the virus capsid (Lonberg-Holm and Yin, 1973) . There is evidence that similar disturbances, with exposure of group-antigenic determinants, occur when Coxsackie B virus particles adsorb on to the surface of Microtitre plates (Katze and Crowell, 1980a and 6) .
Although ELISA detected group-and type-specific antibody responses in the rabbit immune sera, it failed to recognise rising titres of antibody in the paired, acute and convalescent, human sera. Unlike the neutralisation test, ELISA showed, in the paired sera, only the presence of group-reactive antibody which masked the type-specific response. Human sera are more likely than animal immune sera to possess excess group antibody because of the repeated exposure of man to naturally occurring infections with coxsackieviruses (Schmidt et al., 1967) ; all the sera examined in the present investigation were from adults over 31 years old. That most of the antibody present in these sera was group-reactive was confirmed by the highly significant correlation between the ELISA-antibody titres obtained against the different viruses, in contrast to the lack of such correlation for the neutralising antibody titres. ELISA may detect type-specific antibody responses more readily in children, but 20% or more of children have been exposed to infection with one or more coxsackievirus serotypes by 4 years of age (Cramblett et al., 1964; Doerr et al., 1977) . Seven of the 50 adult sera examined showed a group-specific ELISA-antibody response against the Coxsackie B viruses but were without detectable coxsackievirus neutralising antibodies. This is almost certainly due to the wide sharing of group antigens with other members of the enterovirus group, which includes echoviruses and Coxsackie A viruses (Halonen, Rosen and Huebner, 1959; Schmidt et al., 1965 and 1967) .
This masking effect of pre-existing enteroviral group antibody, preventing the demonstration of rising titres of either group-or type-specific antibody following infection with another virus of the group, presents problems in the use of ELISA for the diagnosis of recent infection. An alternative to examining for rising levels of IgG antibody is to test for virus-specific IgM antibody in a single serum specimen. A Coxsackie B virus, or any enterovirus, group-IgM response would facilitate the development of a reliable ELISA test for recent infection, and El-Hagrassy, Banatvala and Coltart (1 980) have described a Coxsackie B virus IgM-antibody-capture technique using a polyvalent mixture of type-specific antigens to give group reactivity. However, recent work from our laboratory suggests that the use of only one of the Coxsackie B viruses as antigen in the indirect-ELISA test is adequate to detect a group-enteroviral IgM-antibody response in sera from adults (G. Hannington, unpublished observations).
